Sigma Healthcare (ASX:SIG) released a trading update for Chemist Warehouse Group’s performance in the first half of FY25, reporting record sales and margin expansion.
The period, ended Dec. 31, 2024, saw growth both in domestic and international markets.
Chemist Warehouse's retail network sales in Australia rose by 12.3% to $4.51 billion, with international sales climbing by 18.4% to $648.2 million.
Overall, total sales increased by 13%, achieving a like-for-like growth of 10.3%.
EBIT increased by 35% to $437.9 million, and the EBIT margin expanded by 400 basis points to 22.3%.
The retail network also expanded, with the opening of 19 new stores, including two in Dubai, marking an entry into a new market.
"CWG has delivered a record result for H1 FY25 with double-digit Like-For-Like Retail Network Sales growth, aided by a strong trading performance in December 2024," said Mario Verrocchi, CEO of Chemist Warehouse Group.
The company reported advancements in its ongoing merger with Sigma, anticipated to conclude in February contributing to further growth and expansion.
Sigma Healthcare is an ASX-listed company whose principal activities are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores.
At the time of reporting, Sigma Healthcare's share price was $2.88.